COSMO Pharmaceuticals N.V. ( ($CH:COPN) ) has provided an update. Cosmo Pharmaceuticals has achieved a significant milestone with the approval of ...
Cosmo Pharmaceuticals N.V. (SIX: COPN), a global leader in AI-driven healthcare and specialty pharmaceuticals, today announced that the Ministry of Food and Drug Safety (MFDS) of the Republic of Korea ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback